Connect your AI

Insulet PODD Stock Issued During Period, Value, Stock Options Exercised

Stock Issued During Period, Value, Stock Options Exercised at other companies

Applied OptoelectronicsAAOI

$0+100%

IQVIAIQV

$16.75M+4.7%

Axsome TherapeuticsAXSM

$9.98M-41.4%

WelltowerWELL

$332K-71.9%

3MMMM

$302M-66.6%

Dycom IndustriesDY

-$478K+76.0%

Other financials

Income statement

Revenue$761.7M+33.9%

Gross profit$529.0M+29.3%

Operating income$122.1M+37.5%

Net income$91.1M+157%

EPS (diluted)$1.30+160%

Balance sheet

Cash & equivalents$480.4M-62.6%

Total debt$969.7M-45.5%

Total equity$1.3B-2.1%

Total assets$3.0B-15.1%

Cash flow

Operating cash flow$113.8M+78.4%

CapEx$24.3M+97.6%

Free cash flow$89.5M+73.8%

Valuation

Market cap$10.1B-19.9%

Enterprise value$10.59B-19.4%

P/E33.3×+2.0×

P/S3.5×-2.3×

Profitability

Gross margin71%+0.6pp

Operating margin17.5%+2.0pp

Net margin10.4%-7.9pp

FCF margin14.3%+1.1pp

Returns & leverage

Return on equity23%-14.9pp

Debt / equity0.7×-0.6×

Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's stock issued during period, value, stock options exercised.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Insulet's stock issued during period, value, stock options exercised?: Insulet (PODD) reported stock issued during period, value, stock options exercised of $400K in Q1 2026.
How has Insulet's stock issued during period, value, stock options exercised changed year-over-year?: Insulet's stock issued during period, value, stock options exercised decreased by 84.0% year-over-year, from $2.5M to $400K.